to 2017 partly from an increase of the management fees in 2018 of Baht 4.6 million due to better performance, sales and marketing expenses increased by Baht 4.9 million or 5.3% and compensation of
% decreased. This was due to an increase in Allowance for doubtful accounts of Baht 10.0 million in Q1/2018 whereas there was a reversal of such transaction of Baht 1.0 million in Q1/2019. The interest expenses
/ 2018. The reason is that sales increase both locally and internationally. Detail of Domestic and Export Sales 2018 9102 selaS ropxE Connxd Ewxx caSn (RKI) 276.70 474404 FSxEh vxgx obpx ond fSui (AF
the period of six months Movement for the second quarter Movement for the period of six months 2019 2018 2019 2018 Increase (decrease) % Increase (decreas e) % Producer and distributor of ready-to
and Q2/2018 respectively, An increase in total revenue 20.4% and can be summarized as following. Q-O-Q Change Q2/2017 Q2/2018 Increase/(Decrease) Sales 196.4 240.8 22.6% The sales volume increases as
that, operating expenses rose by Baht 5.42 million because of the increase of the amount of employee benefit obligations in according with the accounting standard. The ratio of net claim expense over
2017. Net Profit (Loss) for Q3 year 2018 and Q3 year 2017 was 36.54 million baht and 36.54 million baht. It increased 1.22 million baht or 2.41 % from Q3 year 2017. The reason was increase in sales and
the same period of 2018 which has a net profit of 3.19 million baht, an increase of 16.92 million baht or an increase of 529.78 percent by significant changes are as follows - The company has sales
377.85 million, comparing at the same period in 2018 representing 70.30% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up 3.38% due to income from
, Indonesia and India markets experienced in 2019. For Malaysia market, although the TIV shown slightly improved from 2018, but it does not translate into a higher sales revenue mainly the increase was